Centipeda minima extract sensitizes lung cancer cells to DNA-crosslinking agents via targeting Fanconi anemia pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Centipeda minima extract sensitizes lung cancer cells to DNA-crosslinking agents via targeting Fanconi anemia pathway
Authors
Keywords
ECM, NSCLC, Chemoresistance, DNA-crosslinking agents, FANCD2
Journal
PHYTOMEDICINE
Volume 91, Issue -, Pages 153689
Publisher
Elsevier BV
Online
2021-08-06
DOI
10.1016/j.phymed.2021.153689
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-cancer Activity of Centipeda minima Extract in Triple Negative Breast Cancer via Inhibition of AKT, NF-κB, and STAT3 Signaling Pathways
- (2020) Magnolia Muk-Lan Lee et al. Frontiers in Oncology
- Medicinal Plant Centipeda Minima: A Resource of Bioactive Compounds
- (2020) Nguyen Thi Thuy Linh et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- FANCD2 Confers a Malignant Phenotype in Esophageal Squamous Cell Carcinoma by Regulating Cell Cycle Progression
- (2020) Lisa Chan Lei et al. Cancers
- Protection against chemotherapy- and radiotherapy-induced side effects: A review based on the mechanisms and therapeutic opportunities of phytochemicals
- (2020) Yong-Qiang Liu et al. PHYTOMEDICINE
- The Fanconi Anemia Pathway and Fertility
- (2019) Vanessa Tsui et al. TRENDS IN GENETICS
- DNA Repair: Translation to the Clinic
- (2019) E.V. Minten et al. CLINICAL ONCOLOGY
- Traditional Chinese Medicine Preparation Combined Therapy May Improve Chemotherapy Efficacy: A Systematic Review and Meta-Analysis
- (2019) Jiaming Wu et al. Evidence-based Complementary and Alternative Medicine
- Centipeda minima extract exerts antineuroinflammatory effects via the inhibition of NF-κB signaling pathway
- (2019) Si-Yi Li et al. PHYTOMEDICINE
- Celastrol-induced degradation of FANCD2 sensitizes pediatric high-grade gliomas to the DNA-crosslinking agent carboplatin
- (2019) Dennis S. Metselaar et al. EBioMedicine
- Sensitization of tumor cells to chemotherapy by natural products: A systematic review of preclinical data and molecular mechanisms
- (2018) Raimundo Gonçalves de Oliveira Júnior et al. FITOTERAPIA
- Replication stress induces accumulation of FANCD2 at central region of large fragile genes
- (2018) Yusuke Okamoto et al. NUCLEIC ACIDS RESEARCH
- Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
- (2018) Yinghua Zhu et al. Nature Communications
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Mechanism of Ubiquitination and Deubiquitination in the Fanconi Anemia Pathway
- (2017) Sylvie van Twest et al. MOLECULAR CELL
- Suppression of the FA pathway combined with CHK1 inhibitor hypersensitize lung cancer cells to gemcitabine
- (2017) Chun-Hua Dai et al. Scientific Reports
- Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
- (2016) D.A. Fennell et al. CANCER TREATMENT REVIEWS
- Cellular response to DNA interstrand crosslinks: the Fanconi anemia pathway
- (2016) David Lopez-Martinez et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- DNA damage repair and tolerance: a role in chemotherapeutic drug resistance
- (2016) M. R. Salehan et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- Celastrol induces proteasomal degradation of FANCD2 to sensitize lung cancer cells to DNA crosslinking agents
- (2015) Gui-Zhen Wang et al. CANCER SCIENCE
- Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors
- (2015) Yong-Qiang Liu et al. Oncotarget
- Traditional Chinese Medicine: A Treasured Natural Resource of Anticancer Drug Research and Development
- (2014) Chao-Yun Wang et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Cytotoxic activity of two natural sesquiterpene lactones, isobutyroylplenolin and arnicolide D, on human colon cancer cell line HT-29
- (2014) Xuedan Huang et al. NATURAL PRODUCT RESEARCH
- Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway
- (2014) Ping Chen et al. TUMOR BIOLOGY
- Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
- (2014) Wenrui Duan et al. Frontiers in Oncology
- Regulation of FANCD2 by the mTOR Pathway Contributes to the Resistance of Cancer Cells to DNA Double-Strand Breaks
- (2013) C. Shen et al. CANCER RESEARCH
- Small Compound 6-O-Angeloylplenolin Induces Mitotic Arrest and Exhibits Therapeutic Potentials in Multiple Myeloma
- (2011) Ying Liu et al. PLoS One
- FANCD2 Hurdles the DNA Interstrand Crosslink
- (2009) George-Lucian Moldovan et al. CELL
- CHK1 inhibition as a strategy for targeting fanconi anemia (FA) DNA repair pathway deficient tumors
- (2009) Clark C Chen et al. Molecular Cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started